first tirzepatide injection Zepbound 15 mg/0.5 mL — Mountainside Medical tirzepatide 80mg first week weight

Studies show patients who experience mild-to-moderate early nausea often achieve comparable weight and metabolic outcomes as those with minimal side effects, provided they maintain consistent dosing through the adaptation window

, Hazlehurst, J

The daily oral dosing schedule creates a different side effect pattern than weekly injectables, with potentially more consistent but possibly less intense daily GI exposure

Wegovy Wegovy contains the active ingredient semaglutide, a GLP-1 receptor agonist that can help you lose an average of 21% of your starting body weight over 72 weeks at the highest dose: 7.2mg

The follicles stay alive and tend to regrow once weight stabilises and nutrition is restored

Studies in patients with type 2 diabetes show that combining metformin with GLP-1 drugs produces greater HbA1c reductions than either agent alone